683 Capital Management’s Galmed Pharmaceuticals GLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-4,343
| Closed | -$2.71M | – | 137 |
|
|
2020
Q1 | $2.71M | Sell |
4,343
-101
| -2% | -$62.9K | 0.32% | 50 |
|
|
2019
Q4 | $4.62M | Sell |
4,444
-3,091
| -41% | -$3.22M | 0.53% | 36 |
|
|
2019
Q3 | $6.48M | Buy |
7,535
+35
| +0.5% | +$30.1K | 0.72% | 22 |
|
|
2019
Q2 | $9.92M | Hold |
7,500
| – | – | 0.9% | 22 |
|
|
2019
Q1 | $11M | Hold |
7,500
| – | – | 1% | 17 |
|
|
2018
Q4 | $9.22M | Hold |
7,500
| – | – | 0.56% | 22 |
|
|
2018
Q3 | $18.3M | Hold |
7,500
| – | – | 1.19% | 12 |
|
|
2018
Q2 | $16.1M | Buy |
7,500
+3,893
| +108% | +$8.34M | 1.09% | 16 |
|
|
2018
Q1 | $3.62M | Hold |
3,607
| – | – | 0.32% | 47 |
|
|
2017
Q4 | $5.94M | Buy |
3,607
+555
| +18% | +$914K | 0.5% | 35 |
|
|
2017
Q3 | $5.02M | Buy |
3,052
+274
| +10% | +$451K | 0.53% | 36 |
|
|
2017
Q2 | $3.1M | Hold |
2,778
| – | – | 0.46% | 41 |
|
|
2017
Q1 | $2.45M | Buy |
2,778
+365
| +15% | +$321K | 0.38% | 37 |
|
|
2016
Q4 | $1.53M | Buy |
2,413
+657
| +37% | +$415K | 0.11% | 45 |
|
|
2016
Q3 | $1.4M | Buy |
1,756
+792
| +82% | +$633K | 0.15% | 39 |
|
|
2016
Q2 | $779K | Sell |
964
-506
| -34% | -$409K | 0.12% | 37 |
|
|
2016
Q1 | $1.3M | Hold |
1,470
| – | – | 0.23% | 28 |
|
|
2015
Q4 | $2.01M | Hold |
1,470
| – | – | 0.28% | 40 |
|
|
2015
Q3 | $1.97M | Hold |
1,470
| – | – | 0.29% | 36 |
|
|
2015
Q2 | $2.66M | Hold |
1,470
| – | – | 0.55% | 29 |
|
|
2015
Q1 | $2.49M | Sell |
1,470
-19
| -1% | -$32.2K | 0.95% | 29 |
|
|
2014
Q4 | $1.55M | Buy |
1,489
+107
| +8% | +$112K | 0.68% | 27 |
|
|
2014
Q3 | $2.14M | Sell |
1,382
-88
| -6% | -$136K | 0.73% | 26 |
|
|
2014
Q2 | $2.58M | Buy |
1,470
+588
| +67% | +$1.03M | 0.97% | 25 |
|
|
2014
Q1 | $1.82M | Buy |
+882
| New | +$1.82M | 0.71% | 25 |
|